Cronos Group Inc. (CRON) SEC Filings & Earnings Calls
EquiReason read 11 Cronos Group Inc. SEC filings in the last 12 months. Latest: 8-K on 2026-10-15 — Cronos completed acquisition of CanAdelaar, Europe's largest adult-use cannabis company, for €57.5M base purchase price plus earnout, establishing a leading platform in the Netherl.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
- Market cap
- 1.2B
- P/E TTM
- 16.9
- Dividend yield
- 0.5%
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
15 Oct 20268-K · 1.01, 2.01, 7.01Cronos completed acquisition of CanAdelaar, Europe's largest adult-use cannabis company, for €57.5M base purchase price plus earnout, establishing a leading platform in the Netherlands' Wietexperiment.acquisitionopen
Figures in the filing · each found in the filing text
| Net Revenue · CanAdelaar · H1-2026 | $42M | |
| Cultivation Yield · CanAdelaar · 2026 | 20,000 |
Risks flagged
Integration risk and regulatory dependency on Wietexperiment pilot program.
“Acquisition depends on continued success of government-led pilot program; regulatory framework may change.”
11 Sep 20268-K · 1.01Cronos Group extends long stop date for acquisition of CanAdelaar, a licensed cannabis grower in the Dutch Controlled Cannabis Supply Chain Experiment, from Sep 9 to Oct 15, 2026.being acquiredopen
Risks flagged
Acquisition completion risk due to extended long stop date; regulatory uncertainty in Dutch cannabis experiment.
“Extension of long stop date suggests potential delays or conditions not yet met.”
6 Aug 20268-K · 2.02Cronos Group Q2 2026: record net revenue $53M (+58% YoY), record gross profit $28.5M (+96%), record adjusted EBITDA $13.1M (+675%), net income $35.7M, share repurchases 12.3M in H1.earningsopen
Figures in the filing · each found in the filing text
| Net revenue · Q2-2026 | $53M | +58% y/y |
| Gross profit · Q2-2026 | $28M | +96% y/y |
| Gross margin · Q2-2026 | 54.0% | |
| Net income (loss) · Q2-2026 | $36M | |
| Adjusted EBITDA · Q2-2026 | $13M | +675% y/y |
| Cash and cash equivalents and interest-bearing deposits · Q2-2026 | $827M | -1% y/y |
| Capital expenditures · Q2-2026 | $2M | -54% y/y |
Risks flagged
Foreign exchange exposure from Israeli Shekel strength benefiting revenue.
“Net revenue for the current period benefited from the strengthening of the New Israeli Shekel versus the U.S. dollar.” · word for word
Regulatory dependence on cannabis legalization in various jurisdictions.
“Spinach® maintaining #1 market share in vapes and edibles in Canada; PEACE NATURALS® #1 in Israel.” · word for word
6 Aug 202610-QCronos Group reported a strong Q2 2026 with net revenue up 58% YoY and a return to profitability, but faces a new anti-dumping investigation in Israel.earningsopen
Figures in the filing · each found in the filing text
| Net revenue · Q2-2026 | $53M | +58% y/y |
| Gross profit · Q2-2026 | $28M | +96% y/y |
| Gross margin · Q2-2026 | 54.0% | |
| Net income (loss) attributable to Cronos Group · Q2-2026 | $32M | -181% y/y |
| Adjusted EBITDA · Q2-2026 | $13M | +675% y/y |
| Cash and cash equivalents · 2026-06-30 | $467M | -41% y/y |
| Short-term investments · 2026-06-30 | $330M | +725% y/y |
| Cannabis flower revenue · Q2-2026 | $39M | +57% y/y |
| Cannabis extracts revenue · Q2-2026 | $14M | +65% y/y |
| Canada revenue · Q2-2026 | $29M | +50% y/y |
Risks flagged
Anti-Dumping Investigation in Israel
“On August 5, 2026, the Commissioner notified the Company of the initiation of a new investigation.” · word for word
Customer Concentration
“During the three months ended June 30, 2026, the Company earned a total net revenue before excise taxes of $30,804 from two major customers, together accounting for 44% of the Company's total net revenue before excise taxes.” · word for word
Foreign Exchange Volatility
“During the three months ended June 30, 2026, the Company had foreign currency loss on translation of $23.1 million.”
High Tide Loan Credit Risk
“As of June 30, 2026, the High Tide loan receivable included an unamortized discount of $6,921 and an expected credit loss of $4,960.” · word for word
Litigation Risk
“The proposed settlement includes a payment of $10 million to be distributed, after fees and expenses, to members of the settlement class.” · word for word
11 May 20268-K · 1.01, 2.02, 8.01Cronos Group reports Q1 2026 record net revenue $45.2M (+40% YoY); gross profit $19.2M (+39%); net income $15.7M (+103%); Adjusted EBITDA $5.1M (+122%); cash $822M; share repurchase authorization $50M; acquisition of CanAdelaar extended.earningsopen
Figures in the filing · each found in the filing text
| Net revenue · Q1-2026 | $45M | +40% y/y |
| Gross profit · Q1-2026 | $19M | +39% y/y |
| Gross margin · Q1-2026 | 42.0% | |
| Net income · Q1-2026 | $16M | +103% y/y |
| Adjusted EBITDA · Q1-2026 | $5M | +122% y/y |
| Cash and cash equivalents · Q1-2026 | $822M | +3% y/y |
| Capital expenditures · Q1-2026 | $2M | -87% y/y |
Risks flagged
Regulatory risk in Netherlands acquisition; Bibob review and regulatory clearances pending.
“extension provides additional time to satisfy certain closing conditions, including obtaining required regulatory clearances” · word for word
Gross margin slight decline from 43% to 42% due to inventory write-down and mix.
“Gross margin 42% vs 43% YoY”
11 May 202610-QCronos Group reported strong Q1 2026 results: net revenue +40% YoY to $45.2M, net income +103% to $15.7M, Adjusted EBITDA +122% to $5.1M; cash position strong at $822M; new $50M buyback authorized.earningsopen
Figures in the filing · each found in the filing text
| Net revenue · Q1-2026 | $45M | +40% y/y |
| Net income · Q1-2026 | $16M | +103% y/y |
| Gross profit · Q1-2026 | $19M | +40% y/y |
| Gross margin · Q1-2026 | 42.0% | |
| Adjusted EBITDA · Q1-2026 | $5M | +122% y/y |
| Cash and cash equivalents · Q1-2026 | $822M | |
| Operating cash flow · Q1-2026 | $11M | |
| Capital expenditures · Q1-2026 | $2M | -88% y/y |
Risks flagged
Anti-dumping duty risk in Israel
“On November 10, 2024, the Trade Levies Commissioner published final findings under which the Company would be subject to a proposed duty of 175%.” · word for word
Geopolitical risk in Israel
“The Middle East Conflict, including the recent escalation involving the United States, Israel and Iran, has contributed to increased energy and shipping costs.” · word for word
Litigation risk
“The proposed settlement includes a payment of $10 million to be distributed, after fees and expenses, to members of the settlement class.” · word for word
24 Apr 2026DEF 14AProxy statement disclosing executive compensation, governance, and shareholder proposals for 2026 annual meeting.open
Figures in the filing · each found in the filing text
| Net revenue · FY2025 | $147M | -0% y/y |
| Net income (loss) · FY2025 | $-3M | |
| Adjusted EBITDA · FY2025 | $10M | |
| Total Shareholder Return (TSR) - Company · FY2025 | $37.90 | +30% y/y |
| Total Shareholder Return (TSR) - Peer Group · FY2025 | $11.29 | -1% y/y |
| CEO total compensation (SCT) · FY2025 | $4M | -2% y/y |
| CEO Compensation Actually Paid (CAP) · FY2025 | $5M | +26% y/y |
| Average Non-PEO NEO total compensation (SCT) · FY2025 | $1M | +40% y/y |
| Average Non-PEO NEO Compensation Actually Paid (CAP) · FY2025 | $1M | +16% y/y |
| CEO base salary · FY2025 | $775000.00 | 0% y/y |
Risks flagged
Regulatory and legal risks in cannabis industry
“The cannabis industry is highly competitive and rapidly evolving due to stringent regulatory frameworks and changes in economic, market and political conditions.” · word for word
Dependence on Altria relationship
“Altria Group beneficially held 156,573,537 Shares (41.6%) and has significant governance and approval rights.” · word for word
Pending acquisition completion risk
“Closing of the proposed acquisition is subject to certain conditions, including obtaining required regulatory clearances in the Netherlands.” · word for word
Cultivation optimization risk
“As with any cultivation expansion, it typically takes time to fully optimize the new facility.” · word for word
Related party transaction risk
“During 2025, the Company purchased approximately $1,462,000 of products and services directly from such related-party vendor.” · word for word
26 Feb 202610-KCronos Group reported FY2025 revenue of $146.6M (+25% YoY) and gross margin expansion to 43% (+22pp YoY), driven by international cannabis flower sales and production efficiencies.earningsopen
Figures in the filing · each found in the filing text
| Net revenue · FY2025 | $147M | +25% y/y |
| Gross profit · FY2025 | $63M | +149% y/y |
| Gross margin · FY2025 | 43.0% | |
| Net income (loss) attributable to Cronos Group · FY2025 | $-9M | |
| Operating loss · FY2025 | $-17M | |
| Cost of sales · FY2025 | $83M | -9% y/y |
| General and administrative · FY2025 | $42M | -10% y/y |
| Restructuring costs · FY2025 | $2M | +223% y/y |
Risks flagged
Supply constraints in Canadian market
“partially offset by a decrease in cannabis flower sales in the Canadian market due to supply constraints” · word for word
Foreign exchange rate fluctuation
“We are exposed to fluctuations of the U.S. dollar against certain other currencies, particularly the Canadian dollar and Israeli Shekel” · word for word
Dependence on senior management
“Our success is dependent upon the ability, expertise, judgment, discretion and good faith of our senior management.” · word for word
Climate change impact on agriculture
“adverse weather conditions have historically caused volatility in the agricultural industry and consequently in operating results by causing crop failures or significantly reduced harvests” · word for word
26 Feb 20268-K · 2.02Cronos Group reports record Q4/FY2025 revenue: Q4 $44.5M (+47% YoY), FY $146.6M (+25% YoY); gross margin 36%/43%; Adjusted EBITDA positive $0.5M/$10.1M; cash $832M; record Israel revenue; pending CanAdelaar acquisition.earningsopen
Figures in the filing · each found in the filing text
| Net Revenue · Q4-2025 | $45M | +47% y/y |
| Net Revenue · FY2025 | $147M | +25% y/y |
| Gross Profit · Q4-2025 | $16M | +50% y/y |
| Gross Profit · FY2025 | $63M | +149% y/y |
| Gross Margin · Q4-2025 | 36.0% | |
| Gross Margin · FY2025 | 43.0% | |
| Adjusted Gross Profit · Q4-2025 | $16M | +80% y/y |
| Adjusted Gross Profit · FY2025 | $63M | +108% y/y |
| Adjusted Gross Margin · Q4-2025 | 36.0% | |
| Adjusted Gross Margin · FY2025 | 43.0% |
Risks flagged
Foreign currency transaction losses impacted net income; net loss in Q4 despite operational improvements.
“Net loss of $0.5 million in Q4 2025 vs net income of $43.9 million in Q4 2024, driven by foreign currency transaction losses.”
Dependence on international markets, particularly Israel, for growth; regulatory risks in cannabis industry.
“Eighth consecutive quarter of record revenue in Israel; pending acquisition in Netherlands; cannabis regulations vary by jurisdiction.”
6 Nov 20258-K · 2.02Cronos Group reports record Q3 2025 net revenue of $36.3M (+6% YoY), gross profit $18.3M (50% margin), net income $28.3M, and record Adjusted EBITDA of $5.7M; strong balance sheet with $824M cash.earningsopen
Figures in the filing · each found in the filing text
| Net revenue · Q3-2025 | $36M | +6% y/y |
| Gross profit · Q3-2025 | $18M | +408% y/y |
| Gross margin · Q3-2025 | 50.0% | |
| Net income (loss) · Q3-2025 | $28M | +287% y/y |
| Adjusted EBITDA · Q3-2025 | $6M | -194% y/y |
| Cash and cash equivalents · Q3-2025 | $784M | -9% y/y |
| Short-term investments · Q3-2025 | $40M | |
| Capital expenditures · Q3-2025 | $5M | -30% y/y |
Risks flagged
Anti-dumping investigation in Israel could impact import costs and market access.
“Forward-Looking Statements include expectations related to the Anti-Dumping Investigation.”
Middle East conflict poses operational risk to Israel-based revenue, which is a key growth driver.
“Expectations related to the conflict involving Israel, Hamas, Hezbollah, Houthis, Iran and its impact on operations in Israel.”
Temporary flower supply constraints in Canada could limit near-term growth.
“In Canada, despite temporary flower supply constraints, our long-term fundamentals remain strong.” · word for word
6 Nov 202510-QCronos Group reported Q3 2025 net revenue of $36.3M (+6% YoY) and net income of $28.3M, a significant improvement from $7.3M in Q3 2024.earningsopen
Figures in the filing · each found in the filing text
| Net revenue · Q3-2025 | $36M | +6% y/y |
| Gross profit · Q3-2025 | $18M | +408% y/y |
| Net income (loss) attributable to Cronos Group · Q3-2025 | $26M | +211% y/y |
| Operating cash flow · 9M-2025 | $14M | +26% y/y |
| Capital expenditures · 9M-2025 | $24M | +166% y/y |
| Gross margin · Q3-2025 | 50.4% |
Risks flagged
Customer concentration
“During the three months ended September 30, 2025, the Company earned a total net revenue before excise taxes of $22,634 from two major customers, together accounting for 46% of the Company's total net revenue before excise taxes.” · word for word
Credit loss on loan receivable
“Change in allowance for credit loss on non-operating loan (4,771) for three months ended September 30, 2025.” · word for word
Cronos Group Inc. — questions
- What did Cronos Group Inc. file recently?
- 11 SEC filings in the last 12 months. Latest: 8-K on 2026-10-15 — Cronos completed acquisition of CanAdelaar, Europe's largest adult-use cannabis company, for €57.5M base purchase price plus earnout, establishing a leading platform in the Netherlands' Wietexperiment.
Every figure on this page comes from Cronos Group Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.